serine has been researched along with Atherosclerotic Parkinsonism in 8 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, YD | 1 |
| Bao, XQ | 1 |
| Xu, S | 1 |
| Yu, WW | 1 |
| Cao, SN | 1 |
| Hu, JP | 1 |
| Li, Y | 1 |
| Wang, XL | 1 |
| Zhang, D | 1 |
| Yu, SS | 1 |
| Lu, M | 1 |
| Fan, Y | 1 |
| Tang, M | 1 |
| Qian, X | 1 |
| Ding, J | 1 |
| Hu, G | 1 |
| Wessell, RH | 1 |
| Ahmed, SM | 1 |
| Menniti, FS | 1 |
| Dunbar, GL | 1 |
| Chase, TN | 2 |
| Oh, JD | 2 |
| Vaughan, CL | 1 |
| Gründig, E | 1 |
| Raheem, KA | 1 |
| Salvenmoser, F | 1 |
| Schedl, R | 1 |
| Weiss, J | 1 |
| Teelken, AW | 1 |
| van den Berg, GA | 1 |
| Muskiet, FA | 1 |
| Staal-Schreinemachers, AL | 1 |
| Wolthers, BG | 1 |
| Lakke, JP | 1 |
| Narabayashi, H | 2 |
| Kondo, T | 1 |
| Yokochi, F | 1 |
| Nagatsu, T | 1 |
8 other studies available for serine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
A Novel Parkinson's Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Disease Models, Ani | 2016 |
Potentiation of D-serine involves degeneration of dopaminergic neurons in MPTP/p mouse model of Parkinson's disease.
Topics: Animals; Astrocytes; DNA-Binding Proteins; Dopamine; Drug Synergism; Fluorescent Antibody Technique; | 2011 |
NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats.
Topics: Animals; Excitatory Amino Acid Antagonists; Functional Laterality; Levodopa; Locomotion; Male; Neost | 2004 |
Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antibodies; Antiparkinson Agent | 1999 |
Drug-induced parkinsonism in the rat- a model for biochemical investigation of the parkinson-syndrome. III. The incorporation of D-glucose-14C(U) in amino acids of brain and liver from rats pretreated with reserpine or with phenothiazines.
Topics: Amino Acids; Animals; Antipsychotic Agents; Brain; Glucose; Glutamates; Glutamine; Glycine; Liver; M | 1976 |
Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Catecholamines; Dopamine; Droxidopa; Female; Homovanillic Acid | 1989 |
[L-threo-DOPS therapy and parkinsonism].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Antiparkinson Agents; Brain; Dopamine; Droxidopa; Huma | 1986 |
Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia.
Topics: Adult; Aged; Antiparkinson Agents; Droxidopa; Drug Evaluation; Drug Therapy, Combination; Female; Hu | 1987 |